Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review.
Boissier R, Hevia V, Bruins HM, Budde K, Figueiredo A, Lledó-García E, Olsburgh J, Regele H, Taylor CF, Zakri RH, Yuan CY, Breda A. Boissier R, et al. Among authors: hevia v. Eur Urol. 2018 Jan;73(1):94-108. doi: 10.1016/j.eururo.2017.07.017. Epub 2017 Aug 10. Eur Urol. 2018. PMID: 28803033 Review.
Development of urologic de novo malignancies after renal transplantation.
Hevia V, Gómez V, Díez Nicolás V, Alvarez S, Gómez Del Cañizo C, Galeano C, Gomis A, García-Sagredo JM, Marcen R, Burgos FJ. Hevia V, et al. Transplant Proc. 2014 Jan-Feb;46(1):170-5. doi: 10.1016/j.transproceed.2013.12.004. Transplant Proc. 2014. PMID: 24507046
European Association of Urology Guidelines on Renal Transplantation: Update 2018.
Rodríguez Faba O, Boissier R, Budde K, Figueiredo A, Taylor CF, Hevia V, Lledó García E, Regele H, Zakri RH, Olsburgh J, Breda A. Rodríguez Faba O, et al. Among authors: hevia v. Eur Urol Focus. 2018 Mar;4(2):208-215. doi: 10.1016/j.euf.2018.07.014. Epub 2018 Jul 20. Eur Urol Focus. 2018. PMID: 30033070
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma.
Roussel E, Campi R, Larcher A, Verbiest A, Antonelli A, Palumbo C, Derweesh I, Ghali F, Bradshaw A, Meagher MF, Heck M, Amiel T, Kriegmair MC, Rubio J, Musquera M, D'Anna M, Autorino R, Guruli G, Veccia A, Linares-Espinos E, Van Bruwaene S, Hevia V, Porpiglia F, Checcucci E, Minervini A, Mari A, Pavan N, Claps F, Marchioni M, Capitanio U, Beuselinck B, Mir MC, Albersen M; Young Academic Urologists Renal Cell Carcinoma Working Group. Roussel E, et al. Among authors: hevia v. Eur Urol Oncol. 2020 Aug;3(4):523-529. doi: 10.1016/j.euo.2020.04.006. Epub 2020 May 12. Eur Urol Oncol. 2020. PMID: 32414697 Free article.
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC).
Marchioni M, Kriegmair M, Heck M, Amiel T, Porpiglia F, Ceccucci E, Campi R, Minervini A, Mari A, Van Bruwaene S, Linares E, Hevia V, Musquera M, D'Anna M, Derweesh I, Bradshaw A, Autorino R, Guruli G, Veccia A, Roussel E, Albersen M, Pavan N, Claps F, Antonelli A, Palumbo C, Klatte T, Erdem S, Mir MC; EAU-Young Academic Urologist Kidney Cancer Group. Marchioni M, et al. Among authors: hevia v. Eur Urol Oncol. 2021 Apr;4(2):256-263. doi: 10.1016/j.euo.2020.12.010. Epub 2020 Dec 29. Eur Urol Oncol. 2021. PMID: 33384274
58 results